Latest market price
24.19
-0.03-0.12%
TA
Loading chart...
Snapshot
| Index | — | P/E | 13.15 | EPS (ttm) | 1.84 | Insider Own | 3.03% | Shs Outstand | 140.96M | Perf Week | -0.45% |
| Market Cap | 3.41B | Forward P/E | 12.19 | EPS next Y | 1.98 | Insider Trans | 0.00% | Shs Float | 138.35M | Perf Month | -2.97% |
| Enterprise Value | 5.93B | PEG | — | EPS next Q | 0.48 | Short Float | 0.01% | Perf Quarter | -3.47% | ||
| Income | 358.00M | P/S | 6.12 | EPS this Y | 1.29% | Short Ratio | 3.59 | Perf Half Y | -2.46% | ||
| Sales | 557.00M | P/B | 1.47 | EPS next Y | 1.60% | ROA | 7.21% | Short Interest | 7.33K | Perf YTD | -5.10% |
| Book/sh | 16.49 | P/C | 71.04 | EPS next 5Y | -2.16% | ROE | 15.80% | 52W High | 25.71 -5.91% | Perf Year | -4.39% |
| Cash/sh | 0.34 | P/FCF | — | EPS past 3/5Y | 32.79% -1.65% | ROIC | 9.01% | 52W Low | 23.52 2.85% | Perf 3Y | 3.86% |
| Dividend Est. | 1.56 (6.46%) | EV/EBITDA | 13.47 | Sales past 3/5Y | 31.78% 8.91% | Gross Margin | 93.83% | Volatility | 1.25% 1.15% | Perf 5Y | -10.14% |
| Dividend TTM | 1.56 (6.46%) | EV/Sales | 10.64 | EPS Y/Y TTM | 6.98% | Oper. Margin | 79.11% | ATR (14) | 0.28 | Perf 10Y | — |
| Dividend Ex-Date | Oct 15, 2026 | Quick Ratio | 1.41 | Sales Y/Y TTM | 13.44% | Profit Margin | 64.13% | RSI (14) | 42.00 | Recom | — |
| Dividend Gr. 3/5Y | 0.00% 0.00% | Current Ratio | 1.41 | EPS Q/Q | -4.08% | SMA20 | -0.48% | Beta | 0.18 | Target Price | — |
| Payout | 94.96% | Debt/Eq | 1.10 | Sales Q/Q | -13.61% | SMA50 | -2.15% | Rel Volume | 0.27 | Prev Close | 24.22 |
| Employees | 108 | LT Debt/Eq | 1.10 | Earnings | Feb 18 | SMA200 | -3.07% | Avg Volume | 2.87K | Price | 24.19 |
| IPO Date | Sep 27, 2018 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -4.74% -4.50% | Net Debt/EBITDA | 5.72 | Volume | 780 | Change | -0.12% |
Latest News· Times ET
Oct-29-26
Oct-26-26
Oct-26-2606:56PM
Oct-16-26
Oct-16-2606:00AM
Sep-17-26
Sep-17-2604:05PM
Sep-09-26
Sep-09-2606:00AM
Jul-30-26
Company
Hercules Capital, Inc. is a business development company. It focuses on venture lending capital-backed companies in the technology and life science industries. The company was founded in December 2003 and is headquartered in San Mater, CA.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 557 | 547 | 431 | 494 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 48 | 70 | 77 | 68 | — | — | — | — | — | |
| Gross Profit | 523 | 477 | 354 | 426 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 33 | 19 | 20 | 19 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 48 | 93 | 71 | 70 | — | — | — | — | — | |
| Operating Income | 440 | 365 | 263 | 337 | — | — | — | — | — | |
| Interest Expense | 111 | 92 | 77 | 68 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 28 | 67 | 77 | 68 | — | — | — | — | — | |
| Net Income Before Taxes | 358 | 340 | 263 | 337 | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Consolidated Net Income | 358 | 340 | 263 | 337 | — | — | — | — | — | |
| Net Income From Continuing Operations | 358 | 340 | 263 | 337 | — | — | — | — | — | |
| Net Income | 358 | 340 | 263 | 337 | — | — | — | — | — | |
| EPS (Recurring) | 1.93 | 1.90 | 1.61 | 2.32 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.93 | 1.90 | 1.61 | 2.32 | — | — | — | — | — | |
| EPS (Diluted) | 1.84 | 1.85 | 1.61 | 2.31 | — | — | — | — | — | |
| EBITDA | 440 | 365 | 263 | 338 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 13.15 | 13.78 | 15.63 | 10.93 | — | — | — | — | — | |
| Price To Sales Ratio | 8.08 | 8.43 | 9.40 | 7.36 | — | — | — | — | — | |
| Gross Margin | 93.90 | 87.20 | 82.13 | 86.23 | — | — | — | — | — | |
| Operating Margin | 78.99 | 66.73 | 61.02 | 68.22 | — | — | — | — | — | |
| Net Margin | 64.27 | 62.16 | 61.02 | 68.22 | — | — | — | — | — | |
| Shares Outstanding | 186 | 181 | 161 | 144 | — | — | — | — | — | |
| Market Capitalization | 4,499 | 4,614 | 4,052 | 3,636 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| BADAVAS ROBERT P | Director | Mar 26 '26 | Buy | 14.35 | 3,658 | 52,492 | 5,070 | Mar 30 |
| Loo Wade | Director | Mar 26 '26 | Buy | 14.35 | 7,317 | 104,999 | 14,050 | Mar 30 |
| Fallon Thomas J | Director | Mar 26 '26 | Buy | 14.30 | 7,300 | 104,390 | 157,669 | Mar 30 |
| Aguirre DeAnne | Director | Mar 26 '26 | Buy | 14.35 | 7,317 | 104,999 | 10,749 | Mar 30 |
| Randhawa Paramjeet K | Director | Mar 26 '26 | Buy | 14.35 | 2,926 | 41,988 | 22,486 | Mar 30 |
| CROWELL GAYLE A | Director | Mar 26 '26 | Buy | 14.35 | 7,317 | 104,999 | 97,589 | Mar 30 |
| Theodosopoulos Nikos | Director | Mar 26 '26 | Buy | 14.35 | 7,317 | 104,999 | 29,362 | Mar 30 |
| Follmann Christian | Chief Operating Officer | Mar 04 '26 | Buy | 14.68 | 10,000 | 146,800 | 150,135 | Mar 05 |
| Randhawa Paramjeet K | Director | Mar 04 '26 | Buy | 14.78 | 3,050 | 45,079 | 19,560 | Mar 05 |
| Theodosopoulos Nikos | Director | Feb 27 '26 | Buy | 14.21 | 2,600 | 36,946 | 21,523 | Feb 27 |
| BADAVAS ROBERT P | Director | Feb 27 '26 | Buy | 14.27 | 5,000 | 71,350 | 122,073 | Feb 27 |
| Botelho Kiersten Zaza | Chief Legal Officer & CCO | Feb 27 '26 | Buy | 14.21 | 1,300 | 18,473 | 93,336 | Feb 27 |
| Fallon Thomas J | Director | Feb 27 '26 | Buy | 14.20 | 20,000 | 284,000 | 150,369 | Feb 27 |
| Meyer Seth H | Chief Financial Officer | Feb 27 '26 | Buy | 14.33 | 7,000 | 100,310 | 448,553 | Feb 27 |
| Bluestein Scott | Chief Executive Officer | Feb 27 '26 | Buy | 14.35 | 7,000 | 100,450 | 2,516,379 | Feb 27 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.